BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 23160999)

  • 1. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.
    Varrone A; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Booij J; Kapucu OL; Kluge A; Knudsen GM; Koulibaly PM; Nobili F; Pagani M; Sabri O; Vander Borght T; Van Laere K; Tatsch K
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):213-27. PubMed ID: 23160999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related effects and gender differences in Japanese healthy controls for [
    Yamamoto H; Arimura S; Nakanishi A; Shimo Y; Motoi Y; Ishiguro K; Murakami K; Hattori N; Aoki S
    Ann Nucl Med; 2017 Jun; 31(5):407-412. PubMed ID: 28382589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls.
    Buchert R; Kluge A; Tossici-Bolt L; Dickson J; Bronzel M; Lange C; Asenbaum S; Booij J; Atay Kapucu LÖ; Svarer C; Koulibaly PM; Nobili F; Pagani M; Sabri O; Sera T; Tatsch K; Vander Borght T; Van Laere K; Varrone A; Iida H
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1323-36. PubMed ID: 26816194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database.
    Nobili F; Naseri M; De Carli F; Asenbaum S; Booij J; Darcourt J; Ell P; Kapucu O; Kemp P; Svarer C; Morbelli S; Pagani M; Sabri O; Tatsch K; Tossici-Bolt L; Sera T; Vander Borght T; Van Laere K; Varrone A
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):565-73. PubMed ID: 23232506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Tossici-Bolt L; Dickson JC; Sera T; Booij J; Asenbaun-Nan S; Bagnara MC; Borght TV; Jonsson C; de Nijs R; Hesse S; Koulibaly PM; Akdemir UO; Koole M; Tatsch K; Varrone A
    EJNMMI Phys; 2017 Dec; 4(1):8. PubMed ID: 28130765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese multicenter database of healthy controls for [
    Matsuda H; Murata M; Mukai Y; Sako K; Ono H; Toyama H; Inui Y; Taki Y; Shimomura H; Nagayama H; Tateno A; Ono K; Murakami H; Kono A; Hirano S; Kuwabara S; Maikusa N; Ogawa M; Imabayashi E; Sato N; Takano H; Hatazawa J; Takahashi R
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1405-1416. PubMed ID: 29478082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-site
    Fahmi R; Platsch G; Sadr AB; Gouttard S; Thobois S; Zuehlsdorff S; Scheiber C
    Eur J Hybrid Imaging; 2020 Mar; 4(1):5. PubMed ID: 34191214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calibration of gamma camera systems for a multicentre European ¹²³I-FP-CIT SPECT normal database.
    Tossici-Bolt L; Dickson JC; Sera T; de Nijs R; Bagnara MC; Jonsson C; Scheepers E; Zito F; Seese A; Koulibaly PM; Kapucu OL; Koole M; Raith M; George J; Lonsdale MN; Münzing W; Tatsch K; Varrone A
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1529-40. PubMed ID: 21468761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxel-based analysis of age and gender effects on striatal [
    Shigemoto Y; Matsuda H; Kimura Y; Chiba E; Ohnishi M; Nakaya M; Maikusa N; Ogawa M; Mukai Y; Takahashi Y; Sako K; Toyama H; Inui Y; Taki Y; Nagayama H; Ono K; Kono A; Sekiguchi K; Hirano S; Sato N
    Ann Nucl Med; 2022 May; 36(5):460-467. PubMed ID: 35174441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis.
    Frings L; Henninger F; Treppner M; Köber G; Boeker M; Hellwig S; Buchert R; Meyer PT
    J Parkinsons Dis; 2020; 10(4):1457-1465. PubMed ID: 33044193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.
    Rahman MGM; Islam MM; Tsujikawa T; Kiyono Y; Okazawa H
    Ann Nucl Med; 2019 Jan; 33(1):14-21. PubMed ID: 30276622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies?
    Koch W; Hamann C; Welsch J; Pöpperl G; Radau PE; Tatsch K
    J Nucl Med; 2005 Nov; 46(11):1804-11. PubMed ID: 16269593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.
    Varrone A; Sansone V; Pellecchia MT; Amboni M; Salvatore E; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1343-9. PubMed ID: 18283454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome.
    Schiebler T; Apostolova I; Mathies FL; Lange C; Klutmann S; Buchert R
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3302-3312. PubMed ID: 37328621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
    Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls.
    Koch W; Unterrainer M; Xiong G; Bartenstein P; Diemling M; Varrone A; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Booij J; Kapucu OL; Kluge A; Ziebell M; Darcourt J; Nobili F; Pagani M; Hesse S; Vander Borght T; Van Laere K; Tatsch K; la Fougère C
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1938-46. PubMed ID: 24806112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.